Find and Pitch Jounalists, Get Your Story Covered

Tags: Tesla electric vehicles sales IBM qubit

	Profile	Recent Articles on Subject
1	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Remote Interventions From Pharmacists Shown to Improve Blood Glucose Control for Type 2 Diabetes - 6 days ago INHALE-3 Study Data Shows Diabetes Care Is Not “One-Size-Fits-All” - 3 months ago Study: Tirzepatide Results in Weight Loss for Individuals With Type 1 Diabetes - 6 months ago FLOW Trial Results Demonstrate Positive Kidney Outcomes With Semaglutide - 7 months ago Study: Causal Relationship Found Between Pneumonia, Gestational Diabetes - 8 months ago Proposed Biosimilar Liraglutide Shows Non-Inferiority to Reference Drug for Type 2 Diabetes - 9 months ago Dapagliflozin Significantly Reduced A1C in Children, Adolescents With Type 2 Diabetes - 12 months ago Pharmacist-Led Intervention Could Improve Type 2 Diabetes Outcomes for Hispanic Patients - 12 months ago
2	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	Can GLP-1 drugs help with type 1 diabetes? - 6 days ago STAT+: Lilly’s Zepbound slashed risk of developing diabetes - about 1 month ago
3	Kristen Monaco MedPage Today	Microvascular Diabetes Complications Linked to Moderate/Severe Gum Disease - 8 days ago Zepbound Can Prevent Diabetes; Menopause and Cognition; Tandem's Insulin Pump Update - 30 days ago Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues - about 2 months ago Popular Diabetes Drug Class Lowered Risk of 10 Obesity-Associated Cancers - 3 months ago FDA Advisors Not Convinced Once-Weekly Insulin Is Safe in Type 1 Diabetes - 4 months ago Specialty Care Access Not Equal Among Teens With Diabetes - 6 months ago Glucose Changes in Type 1 Diabetes May Affect Thinking Speed - 6 months ago Automated Insulin System OK'd; Zepbound Gains in Popularity; Male Menopause Cures? - 6 months ago Amy Schumer's Cushing's Dx; One Billion People With Obesity; Vitamin D for T1D - 7 months ago Food as Diabetes Medicine? Maybe Not, Trial Suggests - 9 months ago New Diabetes Care Standards; Near 40% Ditch T2D Meds; Zepbound Hits Shelves - 9 months ago JAK Inhibitor Preserves Beta-Cell Function in Early Type 1 Diabetes - 10 months ago 'Alexa, Titrate My Insulin': AI App Boosts Glycemic Control in Randomized Trial - 10 months ago Most Unaware of Having Prediabetes; Mid-Stage Growth Hormone Win; Fake Wegovy Woes - 10 months ago Intermittent Fasting for T2D; Omnipod 5 App Cleared; GLP-1 Meds and Thyroid Cancer - 11 months ago Farxiga Cuts A1c in Pediatric Diabetes; Late-Stage CAH Win; At-Home Menopause Test - 12 months ago Smoking-Related Metabolic Changes Partly Drive Type 2 Diabetes Risk - 12 months ago Hybrid Closed-Loop Insulin System for T1D Safe, Effective During Pregnancy - 12 months ago Diabetes in Night Owls; 'Paradigm-Shifting' Drugs; Transgender Trials Unethical? - about 1 year ago
4	MedPage Today Staff MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Steroid Use Tied to Diabetes; Suicide Rates Climbing; Legionnaire's Death Toll Rises - 8 days ago
5	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Eli Lilly’s once-weekly insulin shows promise in phase 3 trials - 13 days ago
6	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	Lilly has more positive data on its weekly insulin - 14 days ago
7	The Conversation Science Alert Science news. Official account. Australia science news	Type 2 Diabetes Drug Linked to 35% Lower Dementia Risk in Patients - 14 days ago
8	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Eli Lilly Drug Reduces Risk of Diabetes Onset, Building Case for Broader Use of the Therapy - 30 days ago
9	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about Zepbound trial results, an Alnylam heart drug, and more - about 1 month ago STAT+: Pharmalittle: More U.S. states and cities are suing insulin makers; Biden looks to boost U.S. drug manufacturing amid shortages - 10 months ago
10	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Study Finds Semaglutide Improves Chronic Kidney Disease in Patients With Type 2 Diabetes - 4 months ago

Journalists covering type 1 diabetes